Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment candidate for metabolic dysfunction-associated steatohepatitis.
Expion360 (XPON) stock was 57% higher following a 3.9% gain in the previous session.
Longboard Pharmaceuticals (LBPH) shares were up 51% after the company said it agreed to be acquired by Lundbeck in a deal valued at $2.60 billion.
Jasper Therapeutics (JSPR) stock was 26% higher after the company reported that 14 of 15 patients enrolled in both dose cohorts of its phase 1b/2a trial of a treatment candidate for chronic inducible urticaria achieved a clinical response.
B. Riley Financial (RILY) shares were up nearly 23% after the company said it has agreed to sell its Great American Group unit to Oaktree in a deal valued at $386 million.
Price: 3.1300, Change: +1.24, Percent Change: +65.61
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。